kynurenic acid has been researched along with Substance-Related Disorders in 2 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
Substance-Related Disorders: Disorders related to substance use or abuse.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Kynurenic acid (KYNA) is an endogenous negative allosteric modulator of α7nAChRs." | 1.39 | Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid. ( Barnes, C; Bergman, J; Ferré, S; Fratta, W; Goldberg, SR; Justinova, Z; Kangas, BD; Mascia, P; Panlilio, LV; Parashos, A; Pistis, M; Redhi, GH; Scherma, M; Schwarcz, R; Secci, ME; Solinas, M; Tanda, G; Wu, HQ; Zara, T, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Z | 1 |
| Zhang, M | 1 |
| Luo, Y | 1 |
| Ni, X | 1 |
| Lu, H | 1 |
| Wen, Y | 1 |
| Fan, N | 1 |
| Justinova, Z | 1 |
| Mascia, P | 1 |
| Wu, HQ | 1 |
| Secci, ME | 1 |
| Redhi, GH | 1 |
| Panlilio, LV | 1 |
| Scherma, M | 1 |
| Barnes, C | 1 |
| Parashos, A | 1 |
| Zara, T | 1 |
| Fratta, W | 1 |
| Solinas, M | 1 |
| Pistis, M | 1 |
| Bergman, J | 1 |
| Kangas, BD | 1 |
| Ferré, S | 1 |
| Tanda, G | 1 |
| Schwarcz, R | 1 |
| Goldberg, SR | 1 |
2 other studies available for kynurenic acid and Substance-Related Disorders
| Article | Year |
|---|---|
Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls.
Topics: Adult; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Humans; Ketamine; Kynuren | 2020 |
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid.
Topics: Analgesics; Animals; Benzoxazines; Brain; Cannabinoid Receptor Agonists; Conditioning, Operant; Cues | 2013 |